Edition:
United States

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

5.70USD
17 Aug 2018
Change (% chg)

$-0.10 (-1.72%)
Prev Close
$5.80
Open
$5.75
Day's High
$5.88
Day's Low
$5.62
Volume
48,151
Avg. Vol
58,178
52-wk High
$13.15
52-wk Low
$5.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.36 -0.524
Mar '18 10.73 -0.498
FY 2017 Dec '17 7.79 -0.494
Sep '17 6.70 -0.583
Jun '17 5.18 -0.825
Mar '17 5.63 -0.878
FY 2016 Dec '16 3.50 -1.144
Sep '16 1.58 -1.606
Jun '16 1.49 -1.654
Mar '16 2.58 -0.787
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 15.12 16.60 14.20 28.60
Quarter Ending Dec-18 6 18.27 21.30 15.70 36.20
Year Ending Dec-18 6 55.52 60.00 52.00 76.20
Year Ending Dec-19 6 108.20 132.00 94.00 141.97
Earnings (per share)
Quarter Ending Sep-18 6 -0.40 -0.33 -0.47 -0.06
Quarter Ending Dec-18 6 -0.30 -0.10 -0.43 0.08
Year Ending Dec-18 6 -1.71 -1.45 -1.93 -1.62
Year Ending Dec-19 6 -0.34 0.02 -0.64 0.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.29 30.45
P/E High - Last 5 Yrs. -- 42.14 47.36
P/E Low - Last 5 Yrs. -- 23.56 24.74
Beta -- 0.86 0.84
Price to Sales (TTM) 4.52 3.55 5.98
Price to Book (MRQ) -- 3.30 3.69
Price to Tangible Book (MRQ) -- 4.76 5.63
Price to Cash Flow (TTM) -- 19.42 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.78
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -8.80 -5.93
Payout Ratio(TTM) -- 49.41 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 119.41 4.58 7.18
Sales (TTM) vs TTM 1 Yr. Ago 130.08 10.86 12.05
Sales - 5 Yr. Growth Rate -- 6.99 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.42 18.83 23.85
EPS (TTM) vs TTM 1 Yr. Ago 52.84 -- --
EPS - 5 Yr. Growth Rate -- 6.40 7.52
Capital Spending - 5 Yr. Growth Rate -- 7.47 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.84 2.53 2.50
Current Ratio (MRQ) 1.07 3.58 3.53
LT Debt to Equity (MRQ) -- 8.93 11.27
Total Debt to Equity (MRQ) -- 11.33 14.23
Interest Coverage (TTM) -8.07 37.13 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 52.40 55.69 55.23
Gross Margin - 5 Yr. Avg. -- 53.35 53.33
EBITD Margin (TTM) -131.74 -- --
EBITD - 5 Yr. Avg -- 18.82 15.82
Operating Margin (TTM) -140.71 14.40 3.86
Operating Margin - 5 Yr. Avg. -- 14.40 10.95
Pre-Tax Margin (TTM) -164.39 14.69 4.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.64 11.12
Net Profit Margin (TTM) -164.39 11.33 0.98
Net Profit Margin - 5 Yr. Avg. -- 10.95 7.47
Effective Tax Rate (TTM) -- 20.38 20.36
Effective Tax Rate - 5 Yr. Avg. -- 23.80 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 265,029 825,982,481 718,909,906
Net Income/Employee (TTM) -435,688 96,230,889 83,624,743
Receivable Turnover (TTM) 3.09 5.39 5.38
Inventory Turnover (TTM) 1.85 2.45 3.51
Asset Turnover (TTM) 0.36 0.85 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -59.43 10.33 10.04
Return on Assets - 5 Yr. Avg. -- 11.42 10.94
Return on Investment (TTM) -104.07 12.92 12.63
Return on Investment - 5 Yr. Avg. -- 14.82 14.14
Return on Equity (TTM) -1,800.15 14.94 14.82
Return on Equity - 5 Yr. Avg. -- 16.10 15.50
  1 Year 3 Year 5 Year
Sales % 173.30 220.77 --
EPS (TTM) % 48.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Neos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.95%
# of Holders: 117
Total Shares Held: 16,306,161
3 Mo. Net Change: -973,698
# New Positions: 18
# Closed Positions: 14
# Increased Positions: 57
# Reduced Positions: 38
# Net Buyers: 19
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.